Leerink Partnrs Weighs in on Tourmaline Bio Q2 Earnings
Tourmaline Bio, Inc. (NASDAQ:TRML – Free Report) – Analysts at Leerink Partnrs issued their Q2 2025 earnings estimates for shares of Tourmaline Bio in a research note issued to investors on Monday, May 5th. Leerink Partnrs analyst T. Smith forecasts that the company will earn ($0.97) per share for the quarter. The consensus estimate for […]
Tourmaline Bio, Inc. (NASDAQ:TRML – Free Report) – Analysts at Leerink Partnrs issued their Q2 2025 earnings estimates for shares of Tourmaline Bio in a research note issued to investors on Monday, May 5th. Leerink Partnrs analyst T. Smith forecasts that the company will earn ($0.97) per share for the quarter. The consensus estimate for […]
